United States · Series B startup

Who invested in Seneca Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$3.9Mraised across 1 round since 2025, from 1 source

Latest round
Series B, $3.9MAug 2025
Investors
1
See who backed them

The rounds

  1. Aug 2025
    Series B$3.9M

    Source recorded

Everyone who backed them

Keiretsu CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 4 firms list Seneca Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Mid Atlantic Bio AngelsAngel networkPer its own site
VisionTech PartnersAngel networkPer its own site
Dellin InvestmentsFund of fundsPer its own site
NW AngelVC firmPer its own site

Quick answers about Seneca Therapeutics

Who invested in Seneca Therapeutics?

Seneca Therapeutics's investors include Keiretsu Capital.

How much has Seneca Therapeutics raised?

Seneca Therapeutics has raised $3.9M across 1 round since 2025.

When did Seneca Therapeutics last raise?

Seneca Therapeutics's most recent round was a Series B of $3.9M in Aug 2025.

What was Seneca Therapeutics's biggest round?

Its most recent round, $3.9M in Aug 2025, is also its largest on record.

Who backed Seneca Therapeutics first?

Seneca Therapeutics's first round on record, in Aug 2025, was backed by Keiretsu Capital.

What stage is Seneca Therapeutics at?

Seneca Therapeutics's latest named round is a Series B, in Aug 2025.

Where is Seneca Therapeutics based?

Seneca Therapeutics is based in the United States.

Companies like Seneca Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.